2017
DOI: 10.1172/jci.insight.90531
|View full text |Cite
|
Sign up to set email alerts
|

Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 35 publications
0
13
0
Order By: Relevance
“…Published imaging studies confirm that corneal nerve remodeling occurs in patients with ocular GVHD (He et al, 2017a; Tepelus et al, 2017); therefore, clinical studies to delineate the kinetics of disease onset are needed. Complement C3 is a known driver of systemic GVHD (Kwan et al, 2012; Ma et al, 2014; Seignez et al, 2017), and our data show that aberrant complement pathway activation also contributes to the pathogenesis of ocular GVHD including corneal sensation loss. Furthermore, localized CVF treatment preserved corneal sensation in both sexes during ocular GVHD, but treatment only abrogated other facets of ocular surface disease in female mice.…”
Section: Discussionmentioning
confidence: 56%
“…Published imaging studies confirm that corneal nerve remodeling occurs in patients with ocular GVHD (He et al, 2017a; Tepelus et al, 2017); therefore, clinical studies to delineate the kinetics of disease onset are needed. Complement C3 is a known driver of systemic GVHD (Kwan et al, 2012; Ma et al, 2014; Seignez et al, 2017), and our data show that aberrant complement pathway activation also contributes to the pathogenesis of ocular GVHD including corneal sensation loss. Furthermore, localized CVF treatment preserved corneal sensation in both sexes during ocular GVHD, but treatment only abrogated other facets of ocular surface disease in female mice.…”
Section: Discussionmentioning
confidence: 56%
“…Based on these results and on our previous results showing that extracellular GRP94 interacts with the complement C3 4 , we decided to study the intracellular interaction GRP94-C3 in macrophages.…”
Section: Resultsmentioning
confidence: 99%
“…To better understand GRP94 role in macrophages, we analyzed intracellular and cell surface expression of GRP94 in M1 and M2 macrophages derived from PBMC of healthy volunteers, at basal and ER stress conditions. Moreover, as we previously showed that extracellular GRP94 associates with the complement C3 4 and Liszewski et al have reported that shuttling of the intracellular C3-activation-system to the cell surface upon T cell stimulation induces autocrine pro-inflammatory cytokine production 18 , we analyzed the interaction GRP94-C3 in macrophages and studied its potential role in their polarization.…”
Section: Introductionmentioning
confidence: 96%
See 1 more Smart Citation
“…Pope et al discovered that high levels of gp96-IgG complexes exist in the synovial fluids of patients with rheumatoid arthritis (RA), and these gp96 molecules can activate macrophages to secrete inflammatory cytokines such as IL-6 and TNF-α 23 . Patients with type 1 diabetes 24 or with gastrointestinal graft-versus-host disease (GVHD) 25 exhibit high levels of circulating gp96, and gp96 levels correlate with disease severity, supporting the notion that extracellular gp96 is involved in autoimmune conditions. Additionally, Lewis et al found that exogenous gp96 leads to the activation of immune cells in vivo, which in turn leads to the reduction of survival time of mice with pancreatic islet transplantation 26 .…”
mentioning
confidence: 95%